- Home
- SLNO vs ARCB Comparison
SLNO vs ARCB Comparison
Compare SLNO & ARCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLNO | ARCB |
|---|---|---|
| Founded | 1999 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trucking Freight/Courier Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.1B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SLNO | ARCB |
|---|---|---|
| Price | $52.86 | $125.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 12 |
| Target Price | $83.00 | ★ $122.75 |
| AVG Volume (30 Days) | ★ 6.1M | 278.5K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | ★ 108.90 | N/A |
| EPS | 0.39 | ★ 2.62 |
| Revenue | $1,450,788.00 | ★ $1,657,864,000.00 |
| Revenue This Year | $150.46 | $7.00 |
| Revenue Next Year | $50.37 | $5.80 |
| P/E Ratio | $135.49 | ★ $48.43 |
| Revenue Growth | ★ 138.82 | 12.56 |
| 52 Week Low | $29.43 | $58.24 |
| 52 Week High | $89.12 | $135.10 |
Technical Indicators
Market Signals| Indicator | SLNO | ARCB |
|---|---|---|
| Relative Strength Index (RSI) | 77.04 | 73.84 |
| Support Level | $48.91 | $69.33 |
| Resistance Level | $55.47 | N/A |
| Average True Range (ATR) | 0.11 | 5.16 |
| MACD | -0.45 | 0.69 |
| Stochastic Oscillator | 92.86 | 66.26 |
Price Performance
Historical ComparisonAbout SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About ARCB ArcBest Corporation
ArcBest Corp is an integrated logistics company that leverages technology and a full suite of shipping and logistics solutions to meet customers' supply chain needs. The company has two reportable operating segments: Asset-Based, which generates maximum revenue, and Asset-Light. The Asset-Based segment's operations include national, inter-regional, and regional transportation of general commodities through standard, expedited, and guaranteed less-than-truckload services. The Asset-Light segment represents the company's offerings in ground expedite, intermodal, household goods moving, managed transportation, warehousing and distribution, and international freight transportation for air, ocean, and ground.